Does Coronavirus Disease-19 Infection Affect Ovarian Reserve in Infertile Women? A Retrospective Study

Overview

Journal J Hum Reprod Sci

Date 2023 Apr 10

PMID 37033136

Authors

Serkan Kahyaoglu

Muzeyyen Gulnur Ozaksit

Inci Kahyaoglu

Ahmet Arif Filiz

Meryem Kuru Pekcan

Ece Atalay

Ozlem Moraloglu Tekin

Affiliations

Soon will be listed here.

Abstract

Background: Previous studies have revealed menstrual changes following coronavirus disease-19 (COVID-19) disease. The potential impact of COVID-19 on female reproductive organs, ovary in particular, has not been investigated thoroughly.

Aims: The aim of this study was to evaluate changes in serum levels of follicle-stimulating hormone (FSH), luteinising hormone (LH) and oestradiol (E2) following COVID-19 disease as a surrogate for the detection of ovarian vulnerability to SARS-CoV-2 infection.

Settings And Design: In this retrospective study, hospital records of unexplained infertile women between 21 and 40 years old who have attended our institution's reproductive medicine unit for evaluation and/or treatment of infertility have been evaluated.

Materials And Methods: Menstrual cycle day 2-5 serum follicle-stimulating hormone, luteinising hormone and E2 levels of 28 infertile women have been studied both before and after the COVID-19 disease to evaluate ovarian reserve before the ovulation induction treatment cycle.

Statistical Analysis Used: The demographic characteristics and hormonal results of these 28 unexplained infertile women have been compared. The Shapiro-Wilk test has been used to evaluate the normal distribution of variables. Comparison of ovarian reserve markers which were established before and after COVID-19 infection has been performed using paired samples -test.

Results: All patients except one have shown mild COVID-19 symptoms and their infection courses have resulted in uneventful recovery. Serum FSH, LH and E2 levels of 24 (85%) and serum anti-Müllerian hormone (AMH) levels of 4 (15%) patients have been evaluated before and after COVID-19 disease is statistically similar.

Conclusion: COVID-19 disease or inflammatory response of the infection itself does not seem to affect pituitary gonadotropins and ovarian hormones in infertile women based on menstrual cycle day 2-5 serum FSH, LH, E2 and AMH levels. Further studies including higher patient numbers are urgently needed to clarify the potential effects of COVID-19 disease on the gonadal function of women.

Citing Articles

COVID-19 and Female Fertility: An Observational Prospective Multicenter Cohort Study: Upholding Reproductive Rights in Emergency Circumstances.

Gullo G, Lopez A, Loreto C, Cucinella G, La Verde M, Andrisani A Diagnostics (Basel). 2024; 14(19).

PMID: 39410522 PMC: 11475084. DOI: 10.3390/diagnostics14192118.

The Multi-faceted Effects of COVID-19 on Female Reproductive Health: An Updated Narrative Review.

Al-Bdairi A, Makki H, Shawki O, Alkhudair S, Al-Hilli N, Alkhalidi B Cureus. 2024; 16(4):e57944.

PMID: 38738039 PMC: 11082527. DOI: 10.7759/cureus.57944.

Impact of COVID-19 convalescence on pregnancy outcomes in patients undergoing IVF/ICSI during fresh ART cycles: a retrospective cohort study.

Cao M, Han Y, Feng T, Lu P, Wang Y, Sun Q Front Endocrinol (Lausanne). 2024; 14:1298995.

PMID: 38348053 PMC: 10860335. DOI: 10.3389/fendo.2023.1298995.

The effect of COVID-19 and COVID-19 vaccination on serum anti-Mullerian hormone: A systematic review and meta-analysis.

Ghaemi M, Hantoushzadeh S, Shafiee A, Kohandel Gargari O, Fathi H, Eshraghi N Immun Inflamm Dis. 2024; 12(1):e1136.

PMID: 38270314 PMC: 10777886. DOI: 10.1002/iid3.1136.

COVID-19 Vaccination and Reproductive Health: a Comprehensive Review for Healthcare Providers.

Valdes Y, Ledesma B, Reddy R, Paz R, Deshmukh S, Collazo I Reprod Sci. 2023; 31(5):1215-1226.

PMID: 38151655 DOI: 10.1007/s43032-023-01428-0.

References

Fu J, Zhou B, Zhang L, Balaji K, Wei C, Liu X . Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19. Mol Biol Rep. 2020; 47(6):4383-4392. PMC: 7224351. DOI: 10.1007/s11033-020-05478-4. View

Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong J, Turner A . Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Circ Res. 2020; 126(10):1456-1474. PMC: 7188049. DOI: 10.1161/CIRCRESAHA.120.317015. View

Naigaonkar A, Patil K, Joseph S, Hinduja I, Mukherjee S . Ovarian granulosa cells from women with PCOS express low levels of SARS-CoV-2 receptors and co-factors. Arch Gynecol Obstet. 2022; 306(2):547-555. PMC: 9045021. DOI: 10.1007/s00404-022-06567-4. View

Reis F, Bouissou D, Pereira V, Camargos A, Dos Reis A, Santos R . Angiotensin-(1-7), its receptor Mas, and the angiotensin-converting enzyme type 2 are expressed in the human ovary. Fertil Steril. 2010; 95(1):176-81. DOI: 10.1016/j.fertnstert.2010.06.060. View

Chen F, Lou D . Rising Concern on Damaged Testis of COVID-19 Patients. Urology. 2020; 142:42. PMC: 7194680. DOI: 10.1016/j.urology.2020.04.069. View

Jing Y, Run-Qian L, Hao-Ran W, Hao-Ran C, Ya-Bin L, Yang G . Potential influence of COVID-19/ACE2 on the female reproductive system. Mol Hum Reprod. 2020; 26(6):367-373. PMC: 7239105. DOI: 10.1093/molehr/gaaa030. View

Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J . Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 2004; 203(2):622-30. PMC: 7167761. DOI: 10.1002/path.1560. View

Ding T, Wang T, Zhang J, Cui P, Chen Z, Zhou S . Analysis of Ovarian Injury Associated With COVID-19 Disease in Reproductive-Aged Women in Wuhan, China: An Observational Study. Front Med (Lausanne). 2021; 8:635255. PMC: 8017139. DOI: 10.3389/fmed.2021.635255. View

Colaco S, Chhabria K, Singh D, Bhide A, Singh N, Singh A . Expression map of entry receptors and infectivity factors for pan-coronaviruses in preimplantation and implantation stage human embryos. J Assist Reprod Genet. 2021; 38(7):1709-1720. PMC: 8081283. DOI: 10.1007/s10815-021-02192-3. View

10.

Bornstein S, Dalan R, Hopkins D, Mingrone G, Boehm B . Endocrine and metabolic link to coronavirus infection. Nat Rev Endocrinol. 2020; 16(6):297-298. PMC: 7113912. DOI: 10.1038/s41574-020-0353-9. View

11.

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q . Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77(6):683-690. PMC: 7149362. DOI: 10.1001/jamaneurol.2020.1127. View

12.

Dominska K . Involvement of ACE2/Ang-(1-7)/MAS1 Axis in the Regulation of Ovarian Function in Mammals. Int J Mol Sci. 2020; 21(13). PMC: 7369927. DOI: 10.3390/ijms21134572. View

13.

Khalili M, Leisegang K, Majzoub A, Finelli R, Panner Selvam M, Henkel R . Male Fertility and the COVID-19 Pandemic: Systematic Review of the Literature. World J Mens Health. 2020; 38(4):506-520. PMC: 7502312. DOI: 10.5534/wjmh.200134. View

14.

Ashary N, Bhide A, Chakraborty P, Colaco S, Mishra A, Chhabria K . Single-Cell RNA-seq Identifies Cell Subsets in Human Placenta That Highly Expresses Factors Driving Pathogenesis of SARS-CoV-2. Front Cell Dev Biol. 2020; 8:783. PMC: 7466449. DOI: 10.3389/fcell.2020.00783. View

15.

Zou X, Chen K, Zou J, Han P, Hao J, Han Z . Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020; 14(2):185-192. PMC: 7088738. DOI: 10.1007/s11684-020-0754-0. View